Evidence map›Paper›PMID 16319960›Full record

ReviewEMBO reports2005

DNA polymerases and somatic hypermutation of immunoglobulin genes.

Mineaki Seki, Patricia J Gearhart, Richard D Wood

Open access · bronzeAbstract readReview
In one paragraph

Review in EMBO reports, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Tandem Substitutions in Somatic Hypermutation.Frontiers in immunology · 2021
    Article
  4. Article
  5. Memory B Cells in Pregnancy Sensitization.Frontiers in immunology · 2021
    Review
  6. A high-resolution landscape of mutations in theProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Review
  8. Translesion DNA polymerases in eukaryotes: what makes them tick?Critical reviews in biochemistry and molecular biology · 2017
    Review
  9. Article
  10. Accumulation of the FACT complex, as well as histone H3.3, serves as a target marker for somatic hypermutation.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. Article
  12. Article
  13. Review
  14. REV1 and DNA polymerase zeta in DNA interstrand crosslink repair.Environmental and molecular mutagenesis · 2012
    Review
  15. Article
  16. Article
  17. Directed evolution of mammalian anti-apoptosis proteins by somatic hypermutation.Protein engineering, design & selection : PEDS · 2012
    Article
  18. Article
  19. Article
  20. Optimization of DNA polymerase mutation rates during bacterial evolution.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mineaki SekiUniversity of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Patricia J Gearhart
Richard D Wood
UPMC Hillman Cancer Center · USNational Institute on Aging · US

Funding

Repair and Processing of DNA CrosslinksR01CA101980 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WOOD, RICHARD D · 2003 to 2007
$1.7M
DNA Polymerase in Genome Maintenance and TumorigenesisR01CA098675 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WOOD, RICHARD D · 2003 to 2006
$1.3M
Protein Interactions in Antibody DiversityZ01AG000732 · NIA · NATIONAL INSTITUTE ON AGING · PI GEARHART, PATRICIA J · 1996 to 2008
$974k
Intramural NIH HHSNCI NIH HHS CA098675NCI NIH HHS CA101980NCI NIH HHS R01 CA098675NCI NIH HHS R01 CA101980
6 · The paper itself

Abstract

Somatic hypermutation of immunoglobulin variable genes, which increases antibody diversity, is initiated by the activation-induced cytosine deaminase (AID) protein. The current DNA-deamination model posits that AID deaminates cytosine to uracil in DNA, and that mutations are generated by DNA polymerases during replication or repair of the uracil residue. Mutations could arise as follows: by DNA replicating past the uracil; by removing the uracil with a uracil glycosylase and replicating past the resulting abasic site with a low-fidelity polymerase; or by repairing the uracil and synthesizing a DNA-repair patch downstream using a low-fidelity polymerase. In this review, we summarize the biochemical properties of specialized DNA polymerases in mammalian cells and discuss their participation in the mechanisms of hypermutation. Many recent studies have examined mice deficient in the genes that encode various DNA polymerases, and have shown that DNA polymerase H (POLH) contributes to hypermutation, whereas POLI, POLK and several other enzymes do not have major roles. The low-fidelity enzyme POLQ has been proposed as another candidate polymerase because it can efficiently bypass abasic sites and recent evidence indicates that it might participate in hypermutation.

Indexed as

AnimalsCytosine DeaminaseDNA-Directed DNA PolymeraseDNA RepairHumansModels, GeneticSomatic Hypermutation, ImmunoglobulinCytosine DeaminaseDNA-Directed DNA Polymerase

Identifiers

PMID16319960
PMCPMC1369213
OpenAlexW2106452314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.